Prior studies show that people taking GLP-1 medications might face higher odds of ‘aspirating’ food when undergoing procedures requiring anaesthesia, according to report in U.S. News.

Study reveals GLP-1s, popular weight loss and diabetes drugs, can hinder safety of common gastroenterology procedure. Experts advise caution for clinicians.

GLP-1 receptor agonists, also known as GLP-1 analogs, are medications that mimic the action of the GLP-1 hormone, whose primary role is blood sugar regulation by stimulating insulin secretion and ...

A study found that GLP-1 RA use is linked to risks for retained gastric contents during single endoscopic procedures but not with combined upper endoscopy and colonoscopy.

WVU Medicine leads trial of procedure to maintain weight loss without GLP-1 drugs David Beard, The Dominion Post, Morgantown, W.Va. Sun, February 9, 2025 at 12:17 PM UTC ...

The FDA granted breakthrough device designation to an endoscopic procedure that resurfaces the duodenum lining to help people maintain weight loss after discontinuing GLP-1 receptor agonist ...